Helsinn

Helsinn is a privately-owned pharmaceutical group with a broad portfolio of marketed cancer care products and an extensive development pipeline. Since 1976, Helsinn has been focused on developing new treatments to meet more medical needs, committed to improving patients' daily lives, all guided and based on the core family values of respect, integrity, and quality. The group's businesses span pharmaceuticals, biotechnology, and medical devices, with expertise in the research, development, production, and commercialization of therapeutic and supportive care products for cancer, pain, inflammation, and gastrointestinal diseases.